Clinical Trials Browser

Interventional × Neurologic Manifestations × Vorinostat × Clear all

NCT00762255 2013-07-25

A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Phase 1 Completed

Glioblastoma, Neurologic Manifestations